CORRELATION OF CLINICAL, BIOCHEMICAL AND SKELETAL RESPONSES TO l α ‐HYDROXYVITAMIN D₃ IN RENAL BONE DISEASE

Abstract

Thirty-five patients with bone disease and chronic renal failure (twenty-four on maintenance haemodialysis) were treated for 7--39 months with 1alpha-hydroxyvitamin D3, 2--2.5 microgram daily by mouth. Symptoms (bone pain and muscle weakness) and radiographic appearances improved and plasma alkaline phosphatase returned to normal in the majority of patients (87, 76 and 75% respectively). In contrast, histological appearances in bone improved in only 46% twenty-three patients from whom paired biopsies were available, and this change was not greatly different from that seen in a comparable group of untreated patients. Significant correlations were noted in individual patients between the changes in symptoms, X-rays, plasma alkaline phosphatase and immunoreactive parathyroid hormone and these, in turn, were related to histological changes in bone, although these latter changes were often small. It is concluded that 1alpha-hydroxyvitamin D3 is a useful new drug in the treatment of renal bone disease, but that the evaluation of the response depends critically on the method of assessment used.

Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure

“…Patients found to be at particular risk of developing renal bone disease are children, women, those with a long history of renal impairment, and those with predominant tubulointerstitial renal lesions 2. The reported prevalence of renal osteodystrophy varies substantially between studies, however, largely due to differences in the diagnostic criteria used to identify bone disease 3 4 5…”

Effects of Clodronate in Severe Hyperparathyroid Bone Disease in Chronic Renal Failure

“…2). In many bone disorders including renal bone disease, the serum activity of alkaline phos phatase appears to reflect the number of functional osteoblasts [34]. In the absence of changes in liver en zymes, it is likely that this was due to changes in the bone-derived fraction.…”

Vitamin D and analogues in renal bone disease and implications for osteoporosis

“…The prevalence of renal bone disease at the start of dialysis is highest when histological criteria are utilized, intermediate with radiographic criteria and lowest with clinical criteria [2]. There is, however, a close eorrelation between symptoms, radiographie abnormalities and histologieal findings, and improvements in the one are associated with favourable changes in the other [3]. The severity of renal bone disease increases progressively with time on dialysis.…”

“…The predilection of the young and of patients with tubulo-interstitial forms of renal disease to develop renal osteodystrophy may be related, Use of Vitamin D and Related Compounds in Renal Bone Disease respond. There is a correlation between histologically induced changes with treatment and symptomatic improvements [3].…”